Found: 86
Select item for more details and to access through your institution.
Safety and early efficacy of involved-field SBRT for nodal oligo-recurrent prostate cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1434504
- By:
- Publication type:
- Article
Leptin modulated microRNA-628-5p targets Jagged-1 and inhibits prostate cancer hallmarks.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13279-x
- By:
- Publication type:
- Article
Urethrogram-directed stereotactic body radiation therapy for clinically localized prostate cancer in patients with contraindications to magnetic resonance imaging.
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00194
- By:
- Publication type:
- Article
Dysuria following stereotactic body radiation therapy for prostate cancer.
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00151
- By:
- Publication type:
- Article
Stereotactic body radiation therapy for prostate cancer: what is the appropriate patient-reported outcome for clinical trial design?
- Published in:
- Frontiers in Oncology, 2015, v. 5, p. 1, doi. 10.3389/fonc.2015.00077
- By:
- Publication type:
- Article
Improved irritative voiding symptoms 3 years after stereotactic body radiation therapy for prostate cancer.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00290
- By:
- Publication type:
- Article
Clinical characteristics and management of late urinary symptom flare following stereotactic body radiation therapy for prostate cancer.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00122
- By:
- Publication type:
- Article
Human pancreatic cancer-associated stellate cells remain activated after in vivo chemoradiation.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00102
- By:
- Publication type:
- Article
Human pancreatic cancer-associated stellate cells remain activated after in vivo chemoradiation.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 2, doi. 10.3389/fonc.2014.00102
- By:
- Publication type:
- Article
Rationale for stereotactic body radiation therapy in treating patients with oligometastatic hormone-naïve prostate cancer.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00293
- By:
- Publication type:
- Article
Rationale for Stereotactic Body Radiation Therapy in Treating Patients with Oligometastatic Hormone-Naïve Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 2, doi. 10.3389/fonc.2013.00293
- By:
- Publication type:
- Article
Five Fraction Image-Guided Radiosurgery for Primary and Recurrent Meningiomas.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00213
- By:
- Publication type:
- Article
Low incidence of fatigue after hypofractionated stereotactic body radiation therapy for localized prostate cancer.
- Published in:
- Frontiers in Oncology, 2012, v. 2, p. 1, doi. 10.3389/fonc.2012.00142
- By:
- Publication type:
- Article
Low Incidence of Fatigue after Hypofractionated Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2012, v. 2, p. 1, doi. 10.3389/fonc.2012.00142
- By:
- Publication type:
- Article
Cyber Knife with tumor tracking: an effective treatment for high-risk surgical patients with single peripheral lung metastases.
- Published in:
- Frontiers in Oncology, 2012, v. 2, p. 1, doi. 10.3389/fonc.2012.00063
- By:
- Publication type:
- Article
CyberKnife with tumor tracking: An effective alternative to metastectomy for high-risk surgical patients with single peripheral lung metastases.
- Published in:
- Frontiers in Oncology, 2012, v. 2, p. 1, doi. 10.3389/fonc.2012.00063
- By:
- Publication type:
- Article
Impact of neoadjuvant relugolix on patient-reported sexual function and bother.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1377103
- By:
- Publication type:
- Article
Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1381134
- By:
- Publication type:
- Article
Intensity modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: five-year outcomes.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1240939
- By:
- Publication type:
- Article
Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1289249
- By:
- Publication type:
- Article
MicroRNA Profiling in Prostate Cancer - The Diagnostic Potential of Urinary miR-205 and miR-214.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0076994
- By:
- Publication type:
- Article
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer.
- Published in:
- Radiation Oncology, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13014-015-0351-6
- By:
- Publication type:
- Article
Proctitis following stereotactic body radiation therapy for prostate cancer.
- Published in:
- Radiation Oncology, 2014, v. 9, n. 1, p. 223, doi. 10.1186/s13014-014-0277-4
- By:
- Publication type:
- Article
Stereotactic body radiation therapy (SBRT) for prostate cancer in men with large prostates (≥50 cm<sup>3</sup>)
- Published in:
- Radiation Oncology, 2014, v. 9, n. 1, p. 241, doi. 10.1186/s13014-014-0241-3
- By:
- Publication type:
- Article
Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer.
- Published in:
- Radiation Oncology, 2014, v. 9, n. 1, p. 1, doi. 10.1186/1748-717X-9-148
- By:
- Publication type:
- Article
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer.
- Published in:
- Radiation Oncology, 2014, v. 9, n. 1, p. 1, doi. 10.1186/1748-717X-9-52
- By:
- Publication type:
- Article
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Potency preservation following stereotactic body radiation therapy for prostate cancer.
- Published in:
- Radiation Oncology, 2013, v. 8, n. 1, p. 1, doi. 10.1186/1748-717X-8-256
- By:
- Publication type:
- Article
Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer.
- Published in:
- Radiation Oncology, 2013, v. 8, n. 1, p. 1, doi. 10.1186/1748-717X-8-197
- By:
- Publication type:
- Article
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience.
- Published in:
- Radiation Oncology, 2013, v. 8, n. 1, p. 1, doi. 10.1186/1748-717X-8-58
- By:
- Publication type:
- Article
Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety.
- Published in:
- Radiation Oncology, 2013, v. 8, n. 1, p. 1, doi. 10.1186/1748-717X-8-44
- By:
- Publication type:
- Article
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer.
- Published in:
- Radiation Oncology, 2013, v. 8, n. 1, p. 1, doi. 10.1186/1748-717X-8-30
- By:
- Publication type:
- Article
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Potency preservation following stereotactic body radiation therapy for prostate cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
(S009) Intensity-Modulated Radiation Therapy With Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: A Report on Three-Year Toxicity.
- Published in:
- Oncology (08909091), 2016, p. 5
- By:
- Publication type:
- Article
(S044) Patient-Reported Quality of Life After Stereotactic Body Radiotherapy (SBRT), Intensity-Modulated Radiotherapy (IMRT), and Brachytherapy.
- Published in:
- Oncology (08909091), 2015, v. 29, p. 1
- By:
- Publication type:
- Article
(P127) Stereotactic Accelerated Partial Breast Irradiation (SAPBI) for Early-Stage Breast Cancer: Rationale, Feasibility, and Early Experience Using the CyberKnife Radiosurgery Delivery Platform.
- Published in:
- Oncology (08909091), 2015, v. 29, p. 1
- By:
- Publication type:
- Article
Knockdown of microRNA-214-3p Promotes Tumor Growth and Epithelial-Mesenchymal Transition in Prostate Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5875, doi. 10.3390/cancers13235875
- By:
- Publication type:
- Article
MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-46170-3
- By:
- Publication type:
- Article
Treatment Interruptions During Stereotactic Body Radiotherapy for Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.796496
- By:
- Publication type:
- Article
Lobar Gross Endobronchial Disease Predicts for Overall Survival and Grade 5 Pulmonary Toxicity in Medically Inoperable Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.728519
- By:
- Publication type:
- Article
Bothersome Hematospermia Following Stereotactic Body Radiation Therapy for Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.765171
- By:
- Publication type:
- Article
Bleeding Risk Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer in Men on Baseline Anticoagulant or Antiplatelet Therapy.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.722852
- By:
- Publication type:
- Article
Ten-Year Single Institutional Analysis of Geographic and Demographic Characteristics of Patients Treated With Stereotactic Body Radiation Therapy for Localized Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.616286
- By:
- Publication type:
- Article
Rationale for Involved Field Stereotactic Body Radiation Therapy-Enhanced Intermittent Androgen Deprivation Therapy in Hormone-Sensitive Nodal Oligo-Recurrent Prostate Cancer Following Prostate Stereotactic Body Radiation Therapy.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.606260
- By:
- Publication type:
- Article